Senior insider sale
Chief Financial Officer at NOVOCURE LTD — senior position signals high conviction
$85.3K
6.41K shares
What this filing means
BRACKMANN CHRISTOPH plans to sell 6.41K shares of NOVOCURE LTD valued at approximately $85.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/4/2026ACC: 0001950047-26-002218
Officer· Chief Financial Officer
Since Mar 2026
6.41K
Shares to sell
$85.3K
Approx. market value
6.41K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted stock
Not Applicable
3/4/2026
6.41KTotal acquired6.41K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/4/2026 | Restricted stock Not Applicable | 6.41K | — |
| Total | 6.41K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
6.41K
Market value
$85.3K
3/4/2026
Total
Units
6.41K
Value
$85.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/4/2026 | 6.41K | $85.3K | NASDAQ | Planned |
| Total | 6.41K | $85.3K | ||